Headline
The latest stories from AHA Today.
The Congressional Academic Medicine Caucus and the Association of American Medical Colleges today sponsored a Capitol Hill briefing to highlight the urgent nationwide need for more physicians to treat substance use disorders.
The Centers for Medicare & Medicaid Services will host a Dec. 10 call on its final rule requiring hospitals to disclose payer-specific negotiated rates.
The National Academy of Medicine Action Collaborative on Clinician Well-Being and Resilience yesterday hosted a meeting to identify opportunities to advance clinician well-being based on consensus recommendations released by NAM in October.
In response to a government filing in a court case on site-neutral payment, the AHA, Association of American Medical Colleges and several member hospitals again urged the U.S. District Court for the District of Columbia to enforce its September ruling vacating a CMS rule reducing payments for…
The AHA joined by three other national organizations representing hospitals and health systems sued the federal government in federal district court, challenging last month's Centers for Medicare & Medicaid Services’ final rule mandating that hospitals disclose their privately negotiated rates…
Nearly 2.9 million people selected a 2020 health plan through HealthCare.gov Nov. 1-30, including more than 504,000 last week.
The number of incoming medical students from rural backgrounds — a strong predictor a future physician will practice in a rural community — declined 28% between 2002 and 2017 to 852.
The AHA's Center for Health Innovation today hosted an executive forum in Chicago exploring how artificial intelligence is transforming health care delivery.
A recent Medicare Payment Advisory Committee discussion on consolidation within the health care field “presented a myopic view of the purported dangers of hospital mergers to the exclusion of their many benefits,” AHA said today in a letter to the commission.
The Senate Health, Education, Labor and Pensions Committee today voted 18-5 to approve President’s Trump nomination of Stephen Hahn, M.D., to lead the Food and Drug Administration as commissioner.